U.S.
Genmab Up 28%, Axogen Up 31% on Oct 28, 2026: Which Rally Has a Filing Behind It
On Oct 28, 2026, Axogen rose 31.5%, Genmab 28.3% and ICON 17.0%; only Axogen's rise is confirmed by an 8-K.
Genmab (GMAB) stock: why it moved
Every time Genmab (GMAB) moved sharply, checked against filings and numbers. 3 article(s), newest first.
WEEKLY
5 of 8 Filing-Backed Surges Gave Back Gains Within a Week
Of the 8 filing-backed surges with a trading day since, 5 fell, averaging -1.7%. Report-only moves averaged -6.3% across 9 stocks.
U.S.
Robert Half Up 22% Against a Falling Market: What the Q3 Filing Shows
On Oct. 23, 2026, Robert Half rose on an earnings 8-K, Genmab on a reported Phase 3 result and Netskope with its sector. Only Robert Half's move has a filing behind it.